Stuart Weisbrod, founder of the now-closed Merlin BioMed Group, recently formed Iguana Healthcare Partners and launched a long/short fund on Jan. 1.
Before founding Greenwich, Conn.-based Iguana in the fall of 2009, Weisbrod ran Merlin BioMed, a long/short healthcare-oriented hedge fund he founded in 1998 and closed in December 2007. He served as chief investment officer and the firm’s funds achieved a net annualized return of more than...